long-term prevention of recurrent symptomatic VTE
Showing 1 - 25 of >10,000
Patient Satisfaction and Long-term Safety of Intravesical
Recruiting
- Urinary Tract Infections
- Recurrent Urinary Tract Infection
- Intravesical aminoglycoside instillations
-
Leiden, South Holland, NetherlandsLeiden University Medical Center
May 13, 2022
New Oral Anticoagulants (NOAC) in Stroke Patients
Active, not recruiting
- Stroke
- Atrial Fibrillation
- treatment with NOACs or VKAs
-
Basel, Switzerland
- +1 more
Dec 21, 2022
Carotid Artery Diseases Trial in Kraków (Carotid Artery Stenting)
Recruiting
- Carotid Artery Diseases
- Carotid Artery Stenting
-
Kraków, Maloplska, PolandDepartment of Cardiac and Vascular Diseases, The John Paul II Ho
Mar 14, 2022
Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
Completed
- Post Thrombotic Syndrome
- +2 more
- Villalta phone score > or = to 5
- Villalta phone score < 5
-
Grenoble, FranceCHU Grenoble Alpes
Jan 20, 2023
Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs
Recruiting
- Venous Thromboembolism
- +3 more
- Randomised treatment advice (discontinue vs continue after 3 months)
- +4 more
-
Leiden, South-Holland, Netherlands
- +16 more
Oct 17, 2023
Cancer-associated Thrombosis Trial in Worldwide (Apixaban 5 MG)
Recruiting
- Cancer-associated Thrombosis
- Apixaban 5 MG
-
Graz, Austria
- +112 more
Dec 7, 2022
Anticoagulants and Bleeding Disorders Trial in Padova (Anticoagulant drugs)
Recruiting
- Anticoagulants and Bleeding Disorders
- Anticoagulant drugs
-
Padova, ItalyGiuseppe Camporese
Sep 8, 2021
Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)
Terminated
- Venous Thromboembolism
- Lung Neoplasm
- Tinzaparin Sodium
-
Rennes, Bretagne, France
- +26 more
Nov 14, 2022
Respiratory Tract Infections, Wheezing Lower Respiratory Illness Trial in Italy, Poland, United Kingdom (OM-85, Placebo)
Recruiting
- Respiratory Tract Infections
- Wheezing Lower Respiratory Illness
- OM-85
- Placebo
-
Bari, Italy
- +13 more
Dec 22, 2022
Deep Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Low dose nadroparin, Intermediate dose nadroparin, Low dose
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Low dose nadroparin
- +7 more
-
New York, New York
- +71 more
May 21, 2022
Achilles Tendon Rupture, Ankle Fractures, Venous Thromboembolism Trial in Stockholm (Adjuvant IPC)
Recruiting
- Achilles Tendon Rupture
- +2 more
- Adjuvant IPC
-
Stockholm, SwedenKarolinska University Hospital
Jan 3, 2023
Colorectal Cancer Metastatic, Thromboembolism Trial in Spain (Tinzaparin)
Not yet recruiting
- Colorectal Cancer Metastatic
- Thromboembolism
-
Santiago De Compostela, A Coruña, Spain
- +32 more
Nov 23, 2022
Venous Thromboembolic Disease Trial in France (Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP))
Not yet recruiting
- Venous Thromboembolic Disease
- Full-dose anticoagulant therapy (AC)
- Antiplatelet therapy (AP)
-
Amiens, France
- +27 more
Jan 13, 2023
Venous Thromboembolism Trial in Beijing
Recruiting
- Venous Thromboembolism
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Oct 5, 2023
Sphincterotomy, Endoscopic Trial in Beijing (EST, ECPP)
Recruiting
- Sphincterotomy, Endoscopic
- EST
- ECPP
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2023
Venous Thromboembolism, Arterial Thromboembolism Trial in United States (IMPROVE DD VTE Tool)
Completed
- Venous Thromboembolism
- Arterial Thromboembolism
- IMPROVE DD VTE Tool
-
Manhasset, New York
- +4 more
Jul 29, 2022
Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)
Recruiting
- Deep-Venous Thrombosis
- IPD Device delivered by Converis
- Fraxiparine
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Apr 6, 2022
Recurrent Venous Thromboembolism During Anticoagulant Treatment
Recruiting
- Cancer
- +2 more
-
Chieti, Italy
- +8 more
Mar 2, 2022
Venous Thromboembolism Trial in France (Reduced dose of DOAC, Full dose of DOAC)
Recruiting
- Venous Thromboembolism
- Reduced dose of DOAC
- Full dose of DOAC
-
Amiens, France
- +38 more
Apr 21, 2022
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Bariatric Surgery Trial in Baden, Berne, Bern (Rivaroxaban 10 MG Oral Tablet [Xarelto])
Active, not recruiting
- Bariatric Surgery
- Rivaroxaban 10 MG Oral Tablet [Xarelto]
-
Baden, Switzerland
- +2 more
Dec 14, 2022
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
Learn About Venous Thromboembolism Treatment With Rivaroxaban in
Completed
- Treatment of Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Japan Databases, Japan
- +1 more
Jan 10, 2023
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Urinary Tract Stone Trial in Petah Tikva (WhatsApp health education message)
Recruiting
- Urinary Tract Stone
- WhatsApp health education message
-
Petah Tikva, IsraelRabin Medical Center
Nov 16, 2022